|
⚲
|
| Keyboard |
| Cox Christopher Nixon
✚
|
|
|---|---|
| CIK # | 0002008212 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002008212] | |
| 4 | [0002008212] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cox Christopher Nixon | |
| Newsmax Inc | |
| Alto Neuroscience Inc | |
| High-Trend International Group |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Alto Neuroscience Inc ANRO
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 7,189 | $11.82 | 84,974 |
|
Alto Neuroscience Inc ANRO
Stock Option (right to buy) · derivative
|
2025-05-13 | Grant | 15,287 | $0.00 | |
|
Newsmax Inc NMAX
Option (Right to Buy) · derivative
|
2025-03-28 | Grant | 17,500 | $0.00 | |
|
Alto Neuroscience Inc ANRO
Stock Option (right to buy) · derivative
|
2025-01-02 | Grant | 25,236 | $3.17 | 79,998 |
|
Alto Neuroscience Inc ANRO
Common Stock
|
2024-02-06 | Conversion | 588,898 | ||
|
Alto Neuroscience Inc ANRO
Series C Preferred Stock · derivative
|
2024-02-06 | Conversion | 281,917 | $0.00 | |
|
Alto Neuroscience Inc ANRO
Common Stock
|
2024-02-06 | Conversion | 126,755 | ||
|
Alto Neuroscience Inc ANRO
Series B Preferred Stock · derivative
|
2024-02-06 | Conversion | 1,250,000 | $0.00 | |
|
Alto Neuroscience Inc ANRO
Stock Option (right to buy) · derivative
|
2024-02-01 | Grant | 30,574 | $0.00 | |
|
Alto Neuroscience Inc ANRO
Stock Option (right to buy) · derivative
|
2024-02-01 | Grant | 4,623 | $11.88 | 54,921 |